Rafal Krejza, DO
Interventional Pain Medicine · Omaha, NENPI 1619236213
Payments from drug & device makers
Across 669 payments — averaging $19.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Medtronic$2K
- Abbott$1K
- Boston Scientific$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$786
- Scilex Pharmaceuticals Inc.$692
- plus $6K from 51 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
Too few interventional pain medicine providers in Nebraskato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional pain medicine in Omaha
- Jery InbarasuOmaha$12K
- Kevin BalterOmaha$11K
- Madhuri AreOmaha$904
- Pravardhan BirthiGrand Island$102K
- Soubrata RaikarFremont$38K
- Clayton DammeLincoln$21K
- Kelly ZachLincoln$15K
- Thomas BrooksElkhorn$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.